Affinage

NKX3-2

Homeobox protein Nkx-3.2 · UniProt P78367

Length
333 aa
Mass
34.8 kDa
Annotated
2026-04-29
60 papers in source corpus 25 papers cited in narrative 25 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

NKX3-2 (Bapx1) is a homeodomain transcription factor that functions as a sequence-specific transcriptional repressor essential for chondrogenesis, skeletal patterning, and gut morphogenesis. It binds DNA at HRAGTG consensus motifs and represses key targets including Runx2 and Pax3, thereby promoting chondrocyte differentiation while blocking hypertrophic maturation; this repressor activity depends on recruitment of an HDAC1/Sin3A complex via BMP-activated Smad1/Smad4, and NKX3-2 forms a positive autoregulatory loop with Sox9 downstream of Shh signaling (PMID:11702952, PMID:12154128, PMID:14612411, PMID:15703179). Beyond transcriptional repression, NKX3-2 promotes chondrocyte survival by constitutively activating nuclear NF-κB/RelA through direct interaction with the RelA–IκBα complex and NEMO-IKKβ-dependent IκBα degradation (PMID:17310243, PMID:21606193). NKX3-2 protein stability is controlled by a post-translational cascade involving p300 acetylation, HDAC9-mediated deacetylation, PIASy sumoylation, and RNF4-dependent ubiquitination, as well as Ihh/Wnt5a-triggered proteasomal degradation (PMID:27312341, PMID:22507129). Homozygous loss-of-function mutations in NKX3-2 cause spondylo-megaepiphyseal-metaphyseal dysplasia (SMMD) in humans (PMID:20004766).

Mechanistic history

Synthesis pass · year-by-year structured walk · 18 steps
  1. 2001 High

    Establishing NKX3-2 as a transcriptional repressor required for chondrogenesis resolved the question of how Shh signaling drives somitic cartilage formation — a reverse-function mutant converting repressor to activator blocked chondrogenesis, proving the repressor activity itself is the effector mechanism.

    Evidence Retroviral misexpression and reverse-function mutagenesis in chick somites

    PMID:11702952

    Open questions at the time
    • Identity of direct transcriptional targets was unknown
    • Mechanism of repression (cofactors) not defined
    • Upstream regulation beyond Shh unclear
  2. 2001 Medium

    Demonstrating that Bapx1 represses Bmp4 and Wnt5a in gut mesenchyme revealed a second tissue context — gastrointestinal patterning — extending NKX3-2 function beyond skeletal development.

    Evidence Retroviral overexpression and reverse-function mutant in chick gut

    PMID:11180960

    Open questions at the time
    • Direct DNA binding at Bmp4/Wnt5a loci not demonstrated
    • Gut phenotype not validated in mammalian knockouts at this point
  3. 2002 High

    Identifying a Shh→Nkx3.2⇄Sox9 positive autoregulatory loop dependent on BMP co-signaling explained how transient Shh exposure is converted into stable chondrogenic commitment.

    Evidence Retroviral forced expression in chick somitic mesoderm with BMP signal manipulation

    PMID:12154128

    Open questions at the time
    • Whether the loop operates through direct mutual promoter binding or indirect mechanisms was unresolved
    • Relative contributions of Nkx3.2 vs. Sox9 to downstream target genes unclear
  4. 2003 High

    Three concurrent discoveries defined the upstream regulatory inputs and biochemical basis of NKX3-2 repression: Pax1/Pax9 directly activate the Bapx1 promoter; Meox1/2 bind and activate the same promoter cooperatively with Pax1/Pax9; and BMP-activated Smad1/Smad4 recruit an HDAC1/Sin3A corepressor complex to NKX3-2, explaining how BMP signaling potentiates its repressor function.

    Evidence ChIP, EMSA, promoter reporter assays, Smad4-null rescue, Pax1/Pax9 and Meox1/Meox2 double mutant mice

    PMID:12490554 PMID:14612411 PMID:15024065

    Open questions at the time
    • Whether Pax1/Pax9 and Meox factors bind simultaneously or sequentially was not determined
    • Full repertoire of cofactors beyond HDAC1/Sin3A unknown
  5. 2003 High

    Defining the NKX3-2 DNA-binding consensus (HRAGTG) and showing that a DNA-nonbinding mutant retains repressor activity but loses chondrogenic function established that sequence-specific DNA binding is mechanistically required for in vivo target gene regulation.

    Evidence DNA binding site selection, EMSA, site-directed mutagenesis, in vivo chick chondrogenesis assays

    PMID:12746429

    Open questions at the time
    • Genome-wide identification of direct binding sites not performed
    • How repressor activity without DNA binding operates mechanistically was unexplained
  6. 2005 High

    Identifying Runx2 as a direct transcriptional target repressed by NKX3-2 solved the key question of how NKX3-2 blocks osteogenic differentiation — Runx2 repression is a prerequisite for BMP-2-induced chondrogenesis.

    Evidence Luciferase reporter assays with Runx2 promoter, adenoviral Runx2 rescue, BMP-2-induced chondrogenesis in C3H10T1/2 cells

    PMID:15703179

    Open questions at the time
    • Whether NKX3-2 occupies the Runx2 promoter in vivo (ChIP) was not shown
    • Other osteogenic targets beyond Runx2 not investigated
  7. 2006 High

    Placing NKX3-2 downstream of PTHrP signaling in growth plate chondrocytes, with Runx2 rescue of the NKX3-2-induced maturation block, established NKX3-2 as the key effector through which PTHrP prevents premature chondrocyte hypertrophy.

    Evidence Retroviral misexpression in chick, PTHrP conditional knockout mice, Runx2 rescue experiments

    PMID:16421188

    Open questions at the time
    • Whether PTHrP directly regulates NKX3-2 transcription or post-translationally was not distinguished
    • Relationship to Ihh feedback loop only partially explored
  8. 2007 High

    Discovering that NKX3-2 constitutively activates NF-κB/RelA by physically recruiting the RelA–IκBα complex into the nucleus for proteasome-dependent IκBα degradation revealed a non-transcriptional, pro-survival function distinct from its repressor role.

    Evidence Co-immunoprecipitation, nuclear fractionation, proteasome inhibitor experiments, chondrocyte viability assays

    PMID:17310243

    Open questions at the time
    • Structural basis of NKX3-2–RelA interaction unknown
    • Whether this mechanism operates outside chondrocytes was untested
  9. 2009 Medium

    Genetic studies in Bapx1-null mice confirmed its requirement for antral stomach and pyloric constriction, and epistasis analysis placed Bapx1 downstream of Barx1 in gut mesenchyme patterning.

    Evidence Bapx1(Cre) knock-in mice, Barx1/Bapx1 compound mutant analysis

    PMID:19208343

    Open questions at the time
    • Direct targets of NKX3-2 in gut mesenchyme not identified
    • Mechanism of Barx1-to-Bapx1 transcriptional activation not defined
  10. 2009 High

    Identification of homozygous NKX3-2 mutations in three consanguineous families with spondylo-megaepiphyseal-metaphyseal dysplasia (SMMD) provided human genetic proof that NKX3-2 is essential for endochondral ossification of both axial and appendicular skeleton.

    Evidence Genome-wide homozygosity mapping and candidate gene sequencing in three independent families

    PMID:20004766

    Open questions at the time
    • Precise molecular consequence of patient mutations on protein function not biochemically characterized
    • Genotype-phenotype variability across mutations not explored
  11. 2011 High

    Elucidating the NEMO–IKKβ–βTrCP cascade downstream of NKX3-2 resolved how NKX3-2 activates NF-κB without canonical IκBα phosphorylation — IKKβ phosphorylates NKX3-2 itself at Ser148/168, which recruits βTrCP to ubiquitinate IκBα.

    Evidence Co-immunoprecipitation, phosphorylation site mutagenesis, ubiquitination assays, nuclear fractionation

    PMID:21606193

    Open questions at the time
    • Upstream signal triggering NEMO ubiquitin chain formation unclear
    • In vivo relevance of Ser148/168 phosphorylation not tested in animal models
  12. 2012 Medium

    Three concurrent studies expanded the mechanistic picture: Ihh/Wnt5a signaling was shown to trigger NKX3-2 proteasomal degradation (explaining how hypertrophy proceeds); NKX3-2 was found to directly bind and activate the Col2a1 enhancer independently of Sox9; and NKX3-2 was shown to repress Pax3 to promote chondrogenic over myogenic fate in satellite cells.

    Evidence Ihh/smoothened KO mice, Wnt5a assays, ChIP at Col2a1, Sox9 knockdown rescue, satellite cell culture with retroviral expression

    PMID:22507129 PMID:22511961 PMID:22768305

    Open questions at the time
    • E3 ligase responsible for Ihh/Wnt5a-triggered NKX3-2 ubiquitination not identified
    • ChIP-seq for comprehensive target identification still lacking
    • Satellite cell findings not validated in conditional knockout models
  13. 2016 Medium

    Defining the p300-acetylation → HDAC9-deacetylation → PIASy-sumoylation → RNF4-ubiquitination cascade for NKX3-2 degradation revealed how post-translational modifications orchestrate NKX3-2 protein turnover to control the transition from proliferating to hypertrophic chondrocytes; concurrently, cartilage-specific NKX3-2 overexpression in transgenic mice confirmed postnatal dwarfism from delayed hypertrophy.

    Evidence In vitro PTM assays, dominant-negative/knockdown approaches, conditional transgenic mice with skeletal phenotyping

    PMID:27253464 PMID:27312341

    Open questions at the time
    • Whether the PTM cascade operates in all NKX3-2-expressing tissues is unknown
    • Signals that trigger p300 versus HDAC9 engagement not defined
    • Relative contribution of Ihh/Wnt5a versus HDAC9-PIASy-RNF4 degradation pathways unclear
  14. 2017 Medium

    Showing that NKX3-2 induces HIF-1α degradation through a lysosomal/autophagy pathway involving CHIP and p62 revealed a non-canonical, oxygen-independent mechanism by which NKX3-2 suppresses vascularization in growth plate cartilage.

    Evidence Co-immunoprecipitation, autophagy flux assays, conditional NKX3-2 transgenic mice with growth plate immunohistochemistry

    PMID:28479297

    Open questions at the time
    • Whether NKX3-2 transcriptionally or post-translationally promotes CHIP/p62 is unclear
    • In vivo phenotypic consequences on vascular invasion quantified only at descriptive level
  15. 2019 Medium

    Demonstrating that SIRT6 represses NKX3-2 transcription via H3K9 deacetylation at the NKX3-2 locus in endothelial cells uncovered an unexpected vascular context for NKX3-2, linking it to GATA5-dependent endothelial function.

    Evidence Endothelial-specific SIRT6 KO mice, ChIP for H3K9ac at NKX3-2 promoter

    PMID:30894089

    Open questions at the time
    • Direct transcriptional targets of NKX3-2 in endothelium not identified
    • Whether NKX3-2 functions as repressor in endothelial cells as in chondrocytes is unknown
  16. 2022 High

    Identifying a deeply conserved gnathostome-specific enhancer (JRS1) that drives early jaw-joint Nkx3.2 expression, with CRISPR deletion causing joint fusion, linked NKX3-2 cis-regulation to the evolutionary origin of the vertebrate jaw.

    Evidence Comparative genomics, transgenic enhancer reporters in zebrafish, CRISPR/Cas9 enhancer deletion

    PMID:36377467

    Open questions at the time
    • Transcription factors binding JRS1 not identified
    • Whether JRS1 deletion phenotype is fully penetrant in mammals untested
  17. 2024 Medium

    Finding that NKX3-2 promotes ovarian cancer cell migration by inhibiting HDAC6-dependent lysosomal repositioning and autophagy extended the gene's functional repertoire to cancer biology and non-skeletal autophagy regulation.

    Evidence siRNA knockdown, migration assays, lysosome tracking, ATG7/BECN1 rescue in ovarian cancer cells

    PMID:39513923

    Open questions at the time
    • Mechanism by which NKX3-2 inhibits HDAC6-mediated lysosome repositioning not defined
    • Relevance to in vivo tumor biology not validated
  18. 2025 Medium

    Demonstrating NKX3-2 suppresses necroptosis in retinal pigment epithelium by inducing proteasomal degradation of RIP3 expanded the anti-cell-death function of NKX3-2 beyond chondrocyte survival to retinal degeneration contexts.

    Evidence In vitro RPE assays, in vivo mouse retinal degeneration models, proteasomal degradation assays

    PMID:40891783

    Open questions at the time
    • Whether NKX3-2 directly interacts with RIP3 or acts through an intermediary is unclear
    • Therapeutic relevance in retinal disease not established

Open questions

Synthesis pass · forward-looking unresolved questions
  • The full genome-wide repertoire of direct NKX3-2 transcriptional targets across tissues remains undefined, as no ChIP-seq or CUT&RUN studies have been reported; how the transcriptional repressor and non-transcriptional (NF-κB, HIF-1α, RIP3 degradation) functions are coordinated in different cellular contexts is unresolved.
  • No genome-wide binding profile available
  • Structural basis of NKX3-2 interactions with NF-κB, HDAC, and Smad complexes unknown
  • Integration of multiple degradation pathways (Ihh/Wnt5a vs HDAC9-PIASy-RNF4 vs autophagy) not systematically compared

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0140110 transcription regulator activity 6 GO:0098772 molecular function regulator activity 4 GO:0003677 DNA binding 3
Localization
GO:0005634 nucleus 3
Pathway
R-HSA-1266738 Developmental Biology 6 R-HSA-74160 Gene expression (Transcription) 6 R-HSA-162582 Signal Transduction 5 R-HSA-5357801 Programmed Cell Death 3 R-HSA-9612973 Autophagy 2
Partners
HDAC1NEMORELARNF4RUNX2SMAD1SMAD4SOX9
Complex memberships
HDAC1/Sin3A/Smad1/Smad4 corepressor complexRelA-IκBα-NEMO-IKKβ complex

Evidence

Reading pass · 25 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2001 Nkx3.2 functions as a transcriptional repressor to promote somitic chondrogenesis downstream of Shh signaling; its transcriptional repressor activity is essential for this function, as a 'reverse function' mutant converted into a transcriptional activator inhibits axial chondrogenesis in vivo. Retroviral misexpression in chick somitic tissue, reverse-function mutagenesis, in vivo chondrogenesis assays Developmental cell High 11702952
2002 Shh induces Nkx3.2 expression in somitic tissue, and Nkx3.2 in turn induces Sox9 expression; in the presence of BMP signals, Sox9 and Nkx3.2 form a positive autoregulatory loop, mutually inducing each other's expression to promote axial chondrogenesis. Retroviral forced expression in chick somitic mesoderm, BMP signal manipulation, gene expression analysis Genes & development High 12154128
2003 Nkx3.2 forms a complex in vivo with HDAC1 and Smad1/Smad4 in a BMP-dependent manner; the homeodomain of Nkx3.2 supports HDAC1 interaction and the NK domain supports Smad1 interaction; recruitment of the HDAC/Sin3A complex to Nkx3.2 requires Smad4, demonstrating that BMP-dependent Smads potentiate transcriptional repression by Nkx3.2. Co-immunoprecipitation in vivo, domain mapping with deletion mutants, Smad4-null cell line rescue experiments, reporter assays Molecular and cellular biology High 14612411
2003 Nkx3.2 binds DNA in a sequence-specific manner at the consensus HRAGTG motif (high-affinity site TAAGTG); a DNA-nonbinding point mutant (N200Q) retains transcriptional repressor activity but cannot promote somitic chondrogenesis, demonstrating that DNA binding by Nkx3.2 is required for its pro-chondrogenic function. DNA binding site selection assay, EMSA, site-directed mutagenesis, in vivo chondrogenesis assays in chick somites The Journal of biological chemistry High 12746429
2005 Nkx3.2 is a potent sequence-specific transcriptional repressor of the Runx2 promoter, acting through a regulatory element 0.1 kb upstream of the transcription start site; repression of Runx2 by Nkx3.2 is a prerequisite for BMP-2-induced chondrogenic differentiation in mesenchymal progenitor cells. Luciferase reporter assays, adenoviral Runx2 overexpression, BMP-2-induced chondrogenesis in C3H10T1/2 cells, gene expression analysis The Journal of biological chemistry High 15703179
2006 Nkx3.2/Bapx1 acts as a negative regulator of chondrocyte maturation; PTHrP signaling maintains Nkx3.2 expression in proliferating chondrocytes, and Nkx3.2 represses Runx2 expression to block chondrocyte hypertrophy; forced Nkx3.2 expression or PTHrP blocks maturation, while a reverse-function Nkx3.2 mutant accelerates maturation, and Runx2 misexpression rescues the Nkx3.2-induced blockade. Retroviral misexpression in chick, PTHrP conditional knockout mice, reverse-function mutagenesis, Runx2 rescue experiment Development (Cambridge, England) High 16421188
2007 Nkx3.2 supports chondrocyte survival by constitutively activating RelA (NF-κB) through a ligand-independent mechanism: Nkx3.2 directly interacts with the RelA-IκBα heteromeric complex, recruits it into the nucleus, and activates RelA through proteasome-dependent IκBα degradation in the nucleus. Co-immunoprecipitation, nuclear fractionation, proteasome inhibitor experiments, cell viability assays in chondrocytes Nature cell biology High 17310243
2011 Nkx3.2 triggers constitutive nuclear IKKβ activation through ubiquitin chain-dependent interaction with NEMO (IKKγ), leading to IKKβ-induced phosphorylation of Nkx3.2 at Ser148 and Ser168, which recruits βTrCP to cause IκBα ubiquitination independent of canonical IκBα phosphorylation at Ser32/Ser36. Co-immunoprecipitation, phosphorylation site mutagenesis, nuclear fractionation, ubiquitination assays Molecular and cellular biology High 21606193
2012 Indian Hedgehog (Ihh) signaling triggers proteasomal degradation of Nkx3.2 protein through activation of non-canonical Wnt5a signaling; Ihh suppresses Lrp (Wnt co-receptor) and Sfrp expression to enhance Wnt5a-mediated Nkx3.2 degradation; Nkx3.2 protein levels are elevated in Ihh- or smoothened-deficient mice. Ihh pathway manipulation in chondrocyte cultures, Ihh/smoothened knockout mice, Wnt5a functional assays, Western blotting for protein levels The Biochemical journal Medium 22507129
2012 Nkx3.2 directly binds the Col2a1 enhancer element (confirmed by ChIP assay) and upregulates Col2a1 transcription in a Sox9-independent manner, and can partially restore Col2a1 expression after Sox9 knockdown, demonstrating a direct pro-chondrogenic role independent of the Sox9 regulatory loop. ChIP assay, dual luciferase reporter assay, RNAi knockdown of Sox9, overexpression in C3H10T1/2 cells and N1511 chondrocytes PloS one Medium 22511961
2012 Nkx3.2 and Sox9 act downstream of TGFβ/BMP2 to promote chondrogenic differentiation of muscle satellite cells, with Nkx3.2 acting as a transcriptional repressor to suppress Pax3 promoter activity; a reverse-function Nkx3.2 mutant blocks Sox9-induced chondrogenesis in satellite cells. Chick satellite cell culture with chondrogenic medium, retroviral Nkx3.2/Sox9 expression, reverse-function mutant, Pax3 promoter reporter assays, in vivo mouse fracture healing lineage tracing PloS one Medium 22768305
2016 A post-translational modification cascade regulates Nkx3.2 protein stability: p300 acetylates Nkx3.2, HDAC9 deacetylates it (triggering instability), HDAC9-dependent deacetylation promotes PIASy-mediated sumoylation, and subsequent RNF4-mediated SUMO-targeted ubiquitination leads to proteasomal degradation; this cascade regulates chondrocyte survival and hypertrophic maturation. Co-immunoprecipitation, in vitro acetylation/sumoylation/ubiquitination assays, dominant-negative and knockdown approaches, chondrocyte functional assays Cellular signalling Medium 27312341
2016 Cartilage-specific Nkx3.2 overexpression in vivo (Cre-dependent conditional transgenic mice) causes postnatal dwarfism with significant delays in cartilage hypertrophy in endochondral skeletons, without affecting intramembranous bones, confirming Nkx3.2 inhibits chondrocyte hypertrophic maturation in vivo. Conditional transgenic mouse model (Cre-dependent), skeletal phenotyping, histological analysis of growth plates Journal of cellular physiology High 27253464
2017 Nkx3.2 induces oxygen concentration-independent and proteasome-independent (lysosomal/macroautophagy) degradation of HIF-1α protein in chondrocytes, in conjunction with CHIP E3 ligase and p62/SQSTM1 adaptor; cartilage-specific Nkx3.2 overexpression in mice attenuates HIF-1α protein levels and vascularization in growth plates. Co-immunoprecipitation, autophagy flux assays, HIF-1α reporter, conditional transgenic mice, immunohistochemistry Cellular signalling Medium 28479297
2015 PI3K signaling suppresses Nkx3.2 at both mRNA and protein levels in chondrocytes, using p85β (not p85α) as regulatory subunit and requiring Rac1-PAK1 (not Akt) downstream; PI3K-mediated Nkx3.2 suppression promotes chondrocyte hypertrophy, demonstrated in embryonic limb cultures and p85β knockout mice. PI3K inhibitors and activators in chondrocyte cultures, isoform-specific knockdown of p85α/p85β, Rac1-PAK1 inhibitors, p85β KO mice, ex vivo limb cultures Cellular signalling Medium 26363466
2019 SIRT6 inhibits NKX3-2 transcription by deacetylating histone H3K9 at the NKX3-2 locus, thereby inducing GATA5 expression; endothelial-specific SIRT6 knockout mice show increased NKX3-2 expression and impaired GATA5-dependent endothelial function. Endothelial-specific SIRT6 KO mice, ChIP for H3K9 acetylation at NKX3-2 promoter, GATA5 expression analysis, endothelial functional assays Circulation research Medium 30894089
2003 Pax1 and Pax9 directly activate Bapx1 transcription by binding to its promoter region; electrophoretic mobility shift and chromatin immunoprecipitation confirmed physical interaction with the Bapx1 promoter; Bapx1 expression in the sclerotome is lost in Pax1;Pax9 double mutant mice. EMSA, ChIP, transient transfection reporter assays, Pax1/Pax9 double mutant mouse analysis, retroviral overexpression in chick Development (Cambridge, England) High 12490554
2004 Meox1 and Meox2 are required for Bapx1 expression in the sclerotome; Meox1 directly binds a palindromic TAATTA sequence in the Bapx1 promoter (confirmed by EMSA and ChIP), and activates the Bapx1 promoter in a dose-dependent manner enhanced by Pax1/Pax9. Meox1/Meox2 double mutant mice, EMSA, ChIP, transient transfection reporter assays with promoter mutagenesis Molecular and cellular biology High 15024065
2009 Bapx1 is required for antral stomach development and pyloric constriction formation; Bapx1 expression in gut mesenchyme is downstream of Barx1, as Bapx1 expression is lost in the absence of Barx1. Bapx1(Cre) knock-in mice, Barx1/Bapx1 single and compound mutant analysis, gut morphology and marker expression Gastroenterology Medium 19208343
2008 Nkx3.2 and Pax3 establish mutually repressing cell fates in somites downstream of Shh: forced Nkx3.2 expression blocks Pax3 (dermomyotomal marker) in vitro and in vivo, and forced Pax3 expression blocks Shh-mediated sclerotomal gene expression and chondrocyte differentiation in vitro. Presomitic mesoderm explant cultures, retroviral Nkx3.2/Pax3 misexpression, in ovo electroporation, gene expression analysis Developmental biology Medium 18796301
2024 In ovarian cancer cells, NKX3-2 promotes cell migration by inhibiting autophagy; mechanistically, NKX3-2 silencing restores HDAC6-mediated lysosome repositioning to the para-Golgi area, leading to increased autolysosome formation and upregulation of autophagy; silencing autophagy genes ATG7 or BECN1 rescues the migratory phenotype in NKX3-2-silenced cells. siRNA knockdown of NKX3-2, migration assays, lysosome tracking, autophagy flux assays, ATG7/BECN1 double knockdown Cells Medium 39513923
2001 Bapx1 regulates gizzard patterning by repressing Bmp4 and Wnt5a expression; ectopic Bapx1 expression in the proventriculus produces gizzard-like morphology with loss of proventricular Bmp4 and Wnt5a expression, while reverse-function Bapx1 causes ectopic extension of Bmp4 and Wnt5a into the gizzard. Retroviral overexpression and reverse-function mutant in chick gut, gene expression analysis Developmental biology Medium 11180960
2009 Homozygous inactivating mutations in NKX3-2 cause spondylo-megaepiphyseal-metaphyseal dysplasia (SMMD) in humans, confirming NKX3-2 plays an essential role in endochondral ossification of both axial and appendicular skeleton. Genome-wide homozygosity mapping, candidate gene sequencing in three consanguineous families, genotype-phenotype correlation American journal of human genetics High 20004766
2022 A proximal enhancer element (JRS1) deeply conserved in gnathostomes but absent in jawless vertebrates drives early Nkx3.2 expression specifically in the developing jaw joint; CRISPR/Cas9 deletion of JRS1 in zebrafish reduces nkx3.2 expression and causes transient jaw joint deformation and partial fusion. Comparative genomics, transgenic enhancer reporter assays in zebrafish, CRISPR/Cas9 deletion of enhancer, in situ hybridization eLife High 36377467
2025 Nkx3.2 suppresses inflammatory responses and necroptotic cell death in retinal pigment epithelium (RPE) by downregulating pro-inflammatory cytokines and inducing proteasomal degradation of RIP3 (receptor-interacting protein kinase 3), thereby inhibiting necroptosis. In vitro RPE cell assays, in vivo mouse retinal degeneration models, proteasomal degradation assays, transcriptome analysis Investigative ophthalmology & visual science Medium 40891783

Source papers

Stage 0 corpus · 60 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
1999 The murine Bapx1 homeobox gene plays a critical role in embryonic development of the axial skeleton and spleen. Development (Cambridge, England) 200 10572046
2003 Two endothelin 1 effectors, hand2 and bapx1, pattern ventral pharyngeal cartilage and the jaw joint. Development (Cambridge, England) 184 12588851
2002 Shh establishes an Nkx3.2/Sox9 autoregulatory loop that is maintained by BMP signals to induce somitic chondrogenesis. Genes & development 170 12154128
2019 Endothelial SIRT6 Is Vital to Prevent Hypertension and Associated Cardiorenal Injury Through Targeting Nkx3.2-GATA5 Signaling. Circulation research 133 30894089
2001 The chick transcriptional repressor Nkx3.2 acts downstream of Shh to promote BMP-dependent axial chondrogenesis. Developmental cell 113 11702952
2003 Pax1 and Pax9 activate Bapx1 to induce chondrogenic differentiation in the sclerotome. Development (Cambridge, England) 108 12490554
2006 Nkx3.2/Bapx1 acts as a negative regulator of chondrocyte maturation. Development (Cambridge, England) 95 16421188
1997 Bapx1: an evolutionary conserved homologue of the Drosophila bagpipe homeobox gene is expressed in splanchnic mesoderm and the embryonic skeleton. Mechanisms of development 95 9256352
2004 Bapx1 regulates patterning in the middle ear: altered regulatory role in the transition from the proximal jaw during vertebrate evolution. Development (Cambridge, England) 89 14973294
2004 Fgf and Bmp signals repress the expression of Bapx1 in the mandibular mesenchyme and control the position of the developing jaw joint. Developmental biology 88 14729484
2003 Smad-dependent recruitment of a histone deacetylase/Sin3A complex modulates the bone morphogenetic protein-dependent transcriptional repressor activity of Nkx3.2. Molecular and cellular biology 88 14612411
2000 Targeted disruption of the homeobox transcription factor Bapx1 results in lethal skeletal dysplasia with asplenia and gastroduodenal malformation. Genes to cells : devoted to molecular & cellular mechanisms 88 10886375
2004 The splanchnic mesodermal plate directs spleen and pancreatic laterality, and is regulated by Bapx1/Nkx3.2. Development (Cambridge, England) 86 15329346
1999 The homeobox gene NKX3.2 is a target of left-right signalling and is expressed on opposite sides in chick and mouse embryos. Current biology : CB 78 10469600
2005 Nkx3.2-mediated repression of Runx2 promotes chondrogenic differentiation. The Journal of biological chemistry 70 15703179
2009 Role of the homeodomain transcription factor Bapx1 in mouse distal stomach development. Gastroenterology 65 19208343
2006 Histone acetylation dependent allelic expression imbalance of BAPX1 in patients with the oculo-auriculo-vertebral spectrum. Human molecular genetics 57 16407370
2008 A gradient of Shh establishes mutually repressing somitic cell fates induced by Nkx3.2 and Pax3. Developmental biology 44 18796301
2007 Constitutive RelA activation mediated by Nkx3.2 controls chondrocyte viability. Nature cell biology 42 17310243
2002 Transcription factors Nkx3.1 and Nkx3.2 (Bapx1) play an overlapping role in sclerotomal development of the mouse. Mechanisms of development 41 12204261
2001 Gizzard formation and the role of Bapx1. Developmental biology 39 11180960
2012 Interplay of Nkx3.2, Sox9 and Pax3 regulates chondrogenic differentiation of muscle progenitor cells. PloS one 38 22768305
2001 The role of Bapx1 (Nkx3.2) in the development and evolution of the axial skeleton. Journal of anatomy 38 11523821
1997 Molecular cloning, chromosomal mapping and developmental expression of BAPX1, a novel human homeobox-containing gene homologous to Drosophila bagpipe. Gene 36 9426254
2004 Meox homeodomain proteins are required for Bapx1 expression in the sclerotome and activate its transcription by direct binding to its promoter. Molecular and cellular biology 35 15024065
2003 Characterization of Nkx3.2 DNA binding specificity and its requirement for somitic chondrogenesis. The Journal of biological chemistry 33 12746429
2009 Homozygous inactivating mutations in the NKX3-2 gene result in spondylo-megaepiphyseal-metaphyseal dysplasia. American journal of human genetics 29 20004766
2012 Nkx3.2 promotes primary chondrogenic differentiation by upregulating Col2a1 transcription. PloS one 24 22511961
2012 Indian Hedgehog signalling triggers Nkx3.2 protein degradation during chondrocyte maturation. The Biochemical journal 21 22507129
2005 Expression and function of Bapx1 during chick limb development. Anatomy and embryology 21 15887045
2011 Nkx3.2-induced suppression of Runx2 is a crucial mediator of hypoxia-dependent maintenance of chondrocyte phenotypes. Biochemical and biophysical research communications 20 22093831
2016 Cordycepin inhibits chondrocyte hypertrophy of mesenchymal stem cells through PI3K/Bapx1 and Notch signaling pathway. BMB reports 19 27439604
2016 A post-translational modification cascade employing HDAC9-PIASy-RNF4 axis regulates chondrocyte hypertrophy by modulating Nkx3.2 protein stability. Cellular signalling 16 27312341
2014 In vivo genome-wide analysis of multiple tissues identifies gene regulatory networks, novel functions and downstream regulatory genes for Bapx1 and its co-regulation with Sox9 in the mammalian vertebral column. BMC genomics 16 25480362
2014 The role of Nkx3.2 in chondrogenesis. Frontiers in biology 16 27158253
2017 Bapx1 mediates transforming growth factor-β- induced epithelial-mesenchymal transition and promotes a malignancy phenotype of gastric cancer cells. Biochemical and biophysical research communications 15 28315334
2013 Expression pattern of the homeotic gene Bapx1 during early chick gastrointestinal tract development. Gene expression patterns : GEP 14 23727297
1997 Sequence and chromosomal assignment of human BAPX1, a bagpipe-related gene, to 4p16.1: a candidate gene for skeletal dysplasia. Genomics 14 9344671
2020 nkx3.2 mutant zebrafish accommodate jaw joint loss through a phenocopy of the head shapes of Paleozoic jawless fish. The Journal of experimental biology 13 32527964
2021 The broad role of Nkx3.2 in the development of the zebrafish axial skeleton. PloS one 12 34411150
2017 Nkx3.2 induces oxygen concentration-independent and lysosome-dependent degradation of HIF-1α to modulate hypoxic responses in chondrocytes. Cellular signalling 11 28479297
2015 Suppression of Nkx3.2 by phosphatidylinositol-3-kinase signaling regulates cartilage development by modulating chondrocyte hypertrophy. Cellular signalling 11 26363466
2011 Exogenous signal-independent nuclear IkappaB kinase activation triggered by Nkx3.2 enables constitutive nuclear degradation of IkappaB-alpha in chondrocytes. Molecular and cellular biology 11 21606193
2009 A point mutation in the neu1 promoter recruits an ectopic repressor, Nkx3.2 and results in a mouse model of sialidase deficiency. Molecular genetics and metabolism 11 19217813
2021 Zebrafish model for spondylo-megaepiphyseal-metaphyseal dysplasia reveals post-embryonic roles of Nkx3.2 in the skeleton. Development (Cambridge, England) 9 33462117
2018 Aberrant activity of NKL homeobox gene NKX3-2 in a T-ALL subset. PloS one 9 29746601
2018 Bapx1 is required for jaw joint development in amphibians. Evolution & development 9 30168254
2016 Cartilage-Specific and Cre-Dependent Nkx3.2 Overexpression In Vivo Causes Skeletal Dwarfism by Delaying Cartilage Hypertrophy. Journal of cellular physiology 9 27253464
2012 New Bapx1(Cre-EGFP) mouse lines for lineage tracing and conditional knockout studies. Genesis (New York, N.Y. : 2000) 9 21913311
2006 Bapx1 homeobox gene gain-of-function mice show preaxial polydactyly and activated Shh signaling in the developing limb. Developmental dynamics : an official publication of the American Association of Anatomists 8 16791844
2022 A novel cis-regulatory element drives early expression of Nkx3.2 in the gnathostome primary jaw joint. eLife 5 36377467
2018 Bapx1 upregulation is associated with ectopic mandibular cartilage development in amphibians. Zoological letters 5 29942645
2024 Pseudogenization of NK3 homeobox 2 (Nkx3.2) in monotremes provides insight into unique gastric anatomy and physiology. Open biology 4 38955222
2021 Suppression of Osteoarthritis progression by post-natal Induction of Nkx3.2. Biochemical and biophysical research communications 4 34330063
2024 NKX3-2 Induces Ovarian Cancer Cell Migration by HDAC6-Mediated Repositioning of Lysosomes and Inhibition of Autophagy. Cells 3 39513923
2018 A novel NKX3-2 mutation associated with perinatal lethal phenotype of spondylo-megaepiphyseal-metaphyseal dysplasia in a neonate. European journal of medical genetics 3 29704686
2023 Comprehensive Analysis of NKX3.2 in Liver Hepatocellular Carcinoma by Bigdata. Medicina (Kaunas, Lithuania) 2 37893500
2022 BMP7 increases protein synthesis in SW1353 cells and determines rRNA levels in a NKX3-2-dependent manner. PloS one 2 35139106
2016 Genome wide binding (ChIP-Seq) of murine Bapx1 and Sox9 proteins in vivo and in vitro. Genomics data 2 27672560
2025 Nkx3.2 Inhibits Retinal Degeneration by Modulating Inflammation and Cell Death in RPE. Investigative ophthalmology & visual science 0 40891783